Skip to main content
Equibles

Matt Leroux

Analyst

William Blair

Equibles does not estimate personal net worth.

About Matt Leroux

Matt Leroux is recorded as Analyst at William Blair. Matt Leroux has spoken on 5 earnings calls across 5 companies, most recently for Sera Prognostics, Inc. on August 12, 2026. Those appearances were for Sera Prognostics, Inc. (SERA), Stevanato Group S.p.A. (STVN), 10x Genomics, Inc. (TXG), Twist Bioscience Corp (TWST) and Aptargroup, Inc. (ATR). The companies whose calls Matt Leroux spoke on are classified in the Healthcare sector.

Matt Leroux on recent calls

“Just one for me, which is on CE marking, I think targeting fourth quarter now, or I guess by year end for submission versus mid-year. You know, you mentioned some additional data that was asked for.”
Analyst — William Blair, Sera Prognostics, Inc. Q2 FY2026 Earnings Call ·
“Maybe sticking with engineering, you know, I think to hit kind of the guidance range, you need a pretty healthy ramp throughout the year. And you're saying today you have visibility to that.”
Analyst — William Blair, Stevanato Group S.p.A. Q1 FY2026 Earnings Call ·
“One of the follow-up on AI and one is for Adam which is if you could quantify at all either revenue orders related to AI in 25 or the expectation of 26. The second part, Serge, is for you which is I guess a bit higher level.”
Analyst — William Blair, 10x Genomics, Inc. Q4 FY2025 Earnings Call ·
“I want to fall up on the domain reference in terms of AI drag discovery.”
Analyst — William Blair, Twist Bioscience Corp Q1 FY2026 Earnings Call ·
“I wanted to ask about growth expectations. recommendations for the pharma segment. So over the last 12 months, core sales growth has been about 3%.”
Analyst — William Blair, Aptargroup, Inc. Q3 FY2025 Earnings Call ·

Affiliation history

  • William Blair

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity